期刊
CANCER SCIENCE
卷 112, 期 6, 页码 2325-2334出版社
WILEY
DOI: 10.1111/cas.14911
关键词
AKT; head and neck squamous cell carcinoma; immunosuppression; PIK3CA; tumor microenvironment
类别
资金
- Ministry of Education, Culture, Sports, Science and Technology, Japan [20H03834, 20K18243]
- Grants-in-Aid for Scientific Research [20H03834, 20K18243] Funding Source: KAKEN
The PI3K/AKT/mTOR pathway is crucial in head and neck squamous cell carcinoma, particularly with regards to AKT3 expression, which can potentially predict immunoreactivity and prognosis of HNSCC. AKT3-specific inhibition may serve as a novel cancer therapy targeting the PI3K/AKT/mTOR pathway.
The phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway plays a vital role in cell proliferation, apoptosis, metabolism, and angiogenesis in various human cancers, including head and neck squamous cell carcinoma (HNSCC). In the present study, we aimed to clarify the role of AKT, which is a major downstream effector of the PI3K-AKT-mTOR pathway, in HNSCC. We first investigated the mRNA expression of AKT isoforms using RNA-sequencing data from The Cancer Genome Atlas database. We observed a specific elevation of AKT3 expression in HNSCC tissues when compared with that in normal tissues. Furthermore, AKT3 expression correlated with genes related to the immunosuppressive microenvironment more than the other AKT isoforms and PIK3CA. Accordingly, we focused on AKT3 and performed a knockdown approach using an HNSCC cell line. AKT3 knockdown cells exhibited impaired proliferation, a shift in the cell cycle from G2/M to G1/G0 phase, an increase in apoptotic cells, and downregulation of gene expression related to immunosuppression, as well as the knockdown of its upstream regulator PIK3CA. We also performed immunohistochemistry for both AKT3 and PIK3CA using surgical specimens from 72 patients with HNSCC. AKT3 expression in tumor cells correlated with immune cell infiltration and unfavorable prognosis when compared with PIK3CA. These findings suggested that AKT3 expression is a potential biomarker for predicting the immunoreactivity and prognosis of HNSCC. Furthermore, the isoform-specific inhibition of AKT3 could be developed as a novel cancer therapy that efficiently suppresses the PI3K-AKT-mTOR pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据